Jack Anders, Chief Financial Officer at Revolution Medicines, Inc. (RVMD), sold 20,000 shares at $167.34 ($3.4M) on 2026-06-24, disclosed to the SEC on 2026-06-26.
Scheduled sale ($3.4M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $167.34 | 4,553 | $762K | 22.6% |
| 2 | $168.20 | 9,496 | $1.6M | 47.4% |
| 3 | $169.24 | 5,651 | $956K | 28.4% |
| 4 | $170.32 | 300 | $51K | 1.5% |
| Total | $168.33 avg | 20,000 | $3.4M | 100% |
| Filing → |
| RVMD | SELL | 2026-03-19 | $548K | — | Filing → |
| RVMD | SELL | 2026-01-09 | $980K | — | Filing → |
| RVMD | SELL | 2025-12-18 | $479K | — | Filing → |